Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1143]
News [2510]
Articles [153]
Editorials [8]
Conferences [102]
elearning [18]
New prostate cancer risk score could help guide screening decisions
New prostate cancer risk score could help guide screening decisions
FDA grants regular approval to cabozantinib for first-line treatment of advanced renal cell carcinoma
FDA grants regular approval to cabozantinib for first-line treatment of advanced renal cell carcinoma
New class of anti-cancer drug effective against kidney cancer
New class of anti-cancer drug effective against kidney cancer
A kiss of death for prostate cancer
A kiss of death for prostate cancer
Researchers identify a potential molecular trigger for invasiveness in prostate cancer cells
Researchers identify a potential molecular trigger for invasiveness in prostate cancer cells
What does hair loss have to teach us about cancer metastasis?
What does hair loss have to teach us about cancer metastasis?
How defeating THOR could bring a hammer down on cancer
How defeating THOR could bring a hammer down on cancer
Recommendations for genetic counselling and genetic testing for hereditary prostate cancer
Recommendations for genetic counselling and genetic testing for hereditary prostate cancer
Closing in on advanced prostate cancer
Closing in on advanced prostate cancer
NICE recommends lenvatinib for the treatment of advanced renal cell carcinoma (RCC)
NICE recommends lenvatinib for the treatment of advanced renal cell carcinoma (RCC)

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation